Jennifer Humes
Known title: Chief Accounting OfficerCIK: 0002058012
Associated companies
Transaction History
| ROIV | ▼ Sell | Tax Withholding | 3,880 | $154K | 9/20/2026 | View on chart |
| ROIV | ▼ Sell | Tax Withholding | 3,582 | $113K | 6/20/2026 | View on chart |
| ROIV | ▲ Buy | Grant | 29,173 | $0 | 4/20/2026 | View on chart |
| ROIV | ▼ Sell | Open Market | 13,538 | $384K | 4/8/2026 | View on chart |
| ROIV | ▼ Sell | Tax Withholding | 14,526 | $402K | 3/20/2026 | View on chart |
| ROIV | ▲ Buy | Grant | 112,255 | $0 | 3/20/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Roivant Sciences receives downgrades from Wolfe Research and analyst
Wolfe Research lowered Roivant Sciences to a peer‑perform rating. In the same week, an analyst who had been bullish on the company removed that stance, placing Roivant among a list of recent downgrades. The stock is now trading near its $28.03 support level with an RSI below 40, indicating limited upward momentum.
Roivant Sciences receives downgrades from Wolfe Research and analyst. Wolfe Research lowered Roivant Sciences to a peer‑perform rating. In the same week, an analyst who had been bullish on the company removed that stance, placing Roivant among a list of recent downgrades. The stock is now trading near its $28.03 support level with an RSI below 40, indicating limited upward momentum.